Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

干细胞移植生物学的关键问题之一是解决移植排斥问题。 尽管对人类胚胎干细胞进行了三十多年的研究，但人们对控制免疫系统对源自这些细胞的移植物的耐受性的因素知之甚少。 为了实现胚胎干细胞移植治疗疾病的承诺，必须集中努力克服这一巨大障碍。

L'objectif à long terme de notre programme de recherche est la régénération de l'œil malade. La dégénérescence maculaire liée à l'âge, la rétinopathie diabétique et la rétinite pigmentaire sont les ...

CONTEXTE/OBJECTIF : Le placenta et le chorion humains sont des organes embryonnaires transitoires à croissance rapide, construits à partir de diverses populations cellulaires qui sont soit d'origine ...

A major challenge in developing stem cell-based cures for disease is maturing those cells into adult cell types that can be used for transplantation or to study human disease. Dr. Mark Mercola has a ...

Earl J. Beadle Productions, Inc. Stem cells have the potential to treat a wide range of diseases, but developing those cures is a process that has many hurdles. Dr. Hans Keirstead has a CIRM grant to ...

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of Novocell (now ViaCyte), a La ...

Nouveau médecin chercheur universitaire Hôpital pour enfants de Los Angeles La génération et l'expansion de l'intestin grêle créé par ingénierie tissulaire à partir de cellules souches/progénitrices ...

The simple term “stem cell” actually refers to many different types of cells. The tissue-specific stem cells, or adult stem cells, replenish tissues throughout our lives. Embryonic stem cells exist ...

在这里，我们定义了发育中的小鼠内侧和尾部神经节隆起、基底神经节原基和大脑皮层中间神经元的祖细胞和神经元中大约 100 个转录因子 (TF) 的表达。我们已经开始阐明这些基因相对于 Dlx 同源域基因的转录层次，这些基因对于基底节大多数 γ-氨基丁酸能投射 ...

ASCC 提供整个网络的基础设施和运营支持，以推动新型干细胞疗法从实验室走向临床。 ASCC 将让加州服务不足的社区参与进来，以增加教育和获得再生医学试验和治疗的机会。 ASCC 将加速新型再生医学疗法的临床试验管道，并巩固加州作为基因和细胞疗法开发 ...